{"id":"W4402630414","doi":"10.1016/s1474-4422(24)00328-4","title":"Safety and efficacy of evobrutinib in relapsing multiple sclerosis (evolutionRMS1 and evolutionRMS2): two multicentre, randomised, double-blind, active-controlled, phase 3 trials","year":2024,"lang":"en","type":"article","venue":"The Lancet Neurology","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":72,"is_retracted":false,"has_abstract":false,"ca_institutions":"NeuroRx Research (Canada); Montreal Neurological Institute and Hospital","funders":"Merck KGaA; Merck","keywords":"Multiple sclerosis; Medicine; Physical therapy; Phase (matter); Double blind; Physical medicine and rehabilitation; Internal medicine; Alternative medicine; Placebo; Psychiatry; Pathology; Physics","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003617324,0.001677571,0.003270323,0.0004924963,0.0004990517,0.001200134,0.0009273245,0.002531437,0.003829676],"category_scores_gemma":[0.002630558,0.0006076437,0.003200916,0.0004925153,0.001341497,0.00138443,0.0004454368,0.003140327,0.0007320421],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008585995,"about_ca_system_score_gemma":0.0009038717,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007456985,"about_ca_topic_score_gemma":0.001945512,"domain_scores_codex":[0.998844,0.0006518761,0.00008497312,0.0001565565,0.0001022061,0.0001603126],"domain_scores_gemma":[0.9984048,0.0005445516,0.0004619329,0.000117787,0.0001157689,0.0003551395],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9519999,0.002757407,0.001088049,0.001341892,0.002577679,0.00006507819,0.0001033293,0.0003889684,0.003998604,0.0001660993,0.001250473,0.03426247],"study_design_scores_gemma":[0.9406343,0.05332036,0.003295489,0.00008793901,0.000732142,0.00008469578,0.00002696474,0.0001905704,0.0003962454,0.0002276019,0.0009799766,0.00002378146],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9694503,0.02306286,0.0007586835,0.0008796855,0.00041571,0.001737615,0.001185687,0.000114042,0.002395341],"genre_scores_gemma":[0.9831081,0.006487222,0.001573262,0.001831436,0.0004640863,0.00251055,0.001755372,0.00003316713,0.002236767],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003829676,"threshold_uncertainty_score":0.01913053,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.123330611644483,"score_gpt":0.3887133599125956,"score_spread":0.2653827482681126,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}